Latest Shareholder Approvals News

Evergold Minerals has reported a sharply smaller FY2026 loss and a stronger cash position after completing its shift from lithium to gold exploration. The company now has $4.0 million in cash and $4.8 million invested in Western Australian exploration assets, but remains dependent on drilling success and future funding.

Altitude Minerals has secured a $1.215 million placement and plans a further $1.487 million rights issue to fund drilling at its Nevada gold-silver projects. The raising offers free options, but shareholders who do not participate in the non-renounceable offer face dilution.

ABx Group has locked in approximately $4.1 million through a placement and fully underwritten share purchase plan, with strategic partner Good Importing International committing $1 million. The funding will support the Deep Leads rare earths project and construction and commissioning of the ALCORE pilot plant, but comes with substantial new equity and options.

Chariot Resources has secured A$1.1 million from institutional and sophisticated investors to advance its proposed Nigerian lithium acquisition, exploration and partner-funded development program. The raising also brings potential option dilution and only partially addresses the company’s secured debt.

Atlantic Lithium has secured Australian foreign investment approval for Zhejiang Huayou Cobalt’s proposed acquisition, removing one condition to the scheme. Shareholder, court and other regulatory approvals are still required before the transaction can complete.

FOS Capital has completed a $1.55 million placement at $0.12 a share, giving the lighting and electrical services group fresh funding for growth initiatives. A further $310,000 director subscription remains subject to shareholder approval.

Pan African Resources delivered record FY26 production, earnings and cash generation, moving from net debt to a US$185.7 million net cash position. The gold producer is proposing a record dividend and launching a ZAR500 million buy-back, while warning that FY27 costs will rise as it funds further growth.

Cambium Bio has secured firm commitments for a conditional A$7.1 million placement, taking its proposed funding package to A$10.85 million for the pivotal Elate Ocular Phase 3 program. Completion depends on three inter-conditional shareholder resolutions at the company’s expected November AGM.

Fulcrum Lithium has promoted Chief Operating Officer Scott Keenan to Managing Director, placing the executive who led its Alkali Flats discovery in charge of the company’s next project phase. The appointment comes with a $360,000 annual salary and a proposed 4 million performance-rights package subject to shareholder approval.

NoviqTech is seeking shareholder approval to acquire software and source code used by its Carbon Central and Fuel Central platforms from an entity associated with former director Freddy El Turk. Until the vote, the company has only an interim licence, creating a clear continuity risk if approval is not secured.

Investigator Silver has used FY26 to move the Paris Silver Project from feasibility study toward development, backed by A$58.8 million in cash and a maiden ore reserve. The company still faces the harder tests of permitting, financing and construction before its projected silver production can become reality.

ION Video has secured an oversubscribed $4.25 million placement to fund independent trials of its video technology, with directors and management committing a further $1.2 million subject to shareholder approval. The capital will be used to test whether ION’s architecture can deliver measurable technical and financial benefits in real operating environments.